Sector
Pharma Tech
Discover the early-stage Pharma Tech ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Pharma Tech startups.
Discover the early-stage Pharma Tech ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Pharma Tech startups.
Scouts
Share promising startups in this sector and get rewarded if they raise. No prior track record needed.
Investors
Access qualified startups curated by Superscout across pre-seed to seed.
Supporters
Work at a company, lab, or city? Connect with builders in your space.
Pharma tech, a child sector within Superscout's Healthcare category, encompasses the technology platforms that modernize pharmaceutical development, manufacturing, distribution, and commercialization, including clinical trial management, pharmaceutical supply chain, drug pricing and market access, and the digital infrastructure that connects pharmaceutical companies with healthcare providers and patients. With 6 funders actively investing in pharma tech startups tracked in Superscout's database, the sector serves the $1.5+ trillion global pharmaceutical industry.
The pharma tech investment thesis is driven by the enormous inefficiency of pharmaceutical development and commercialization: bringing a new drug to market costs an average of $2.6 billion and takes 10-15 years, with a 90%+ failure rate in clinical trials. Technology that improves any stage of this process, from AI-powered target identification and clinical trial design to digital supply chain management and real-world evidence generation, creates significant value given the scale of pharmaceutical spending.
For pharma tech founders, the 2025-2026 funding environment rewards companies with validated deployments at pharmaceutical companies, clear regulatory understanding, and technology that addresses measurable pain points in the drug development or commercialization process.
